RESEARCH ANTIFUNGAL THERAPY OF OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS


Cite item

Full Text

Abstract

Modern medicine has made significant advances in the treatment of fungal infections. The problem of drug resistance of such a common conditional pathogen as Candida remains relevant for the last decade. The aims of the study were: 1) analysis of species and strain drift of Candida in patients with HIV/AIDS from oropharynx and intestine in two years; 2) the analysis of the dynamics of the sensitivity of Candida to standard antimycotic drugs. Treatment of candidiasis in HIV-infected patients leads to changes in the species and strain composition of Candida. After eradication of C. albicans which is sensitive to fluconazole, more resistant strains of other species (glabratae, krusei. tropicalis) takes its place in the biotope, which is one of the reasons for the low effectiveness of antimycotic therapy.

About the authors

Y. S Filina

State budgetary healthcare institution Infectious Clinical Hospital № 2; Federal State Autonomous Educational Institution for the Higher Education I.M. Sechenov First Moscow State Medical University Ministry of health of Russia

Email: Julia.s.f@mail.ru
doctor in Infectious Diseases hospital № 2, postgraduate student in I.M. Sechenov first Moscow State Medical University, Ministry of health of russia (Sechenov University) 8th str. of Sokolinaya Gora, 15, 105275, Moscow, Russia; 2-4, Bolshaya Pirogovskaya st., 119991, Moscow, Russia

Elena V. Volchkova

State budgetary healthcare institution Infectious Clinical Hospital № 2; Federal State Autonomous Educational Institution for the Higher Education I.M. Sechenov First Moscow State Medical University Ministry of health of Russia

MD, professor, head of Department of Infectious Diseases, Faculty of Preventive Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University) 8th str. of Sokolinaya Gora, 15, 105275, Moscow, Russia; 2-4, Bolshaya Pirogovskaya st., 119991, Moscow, Russia

Yuri V. Nesvizhskiy

Federal State Autonomous Educational Institution for the Higher Education I.M. Sechenov First Moscow State Medical University Ministry of health of Russia

MD, Professor of the Microbiology, Virology and Immunology department, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University) 2-4, Bolshaya Pirogovskaya st., 119991, Moscow, Russia

O. F Belaya

Federal State Autonomous Educational Institution for the Higher Education I.M. Sechenov First Moscow State Medical University Ministry of health of Russia

MD, professor of Department of Infectious Diseases, Faculty of Preventive Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University) 2-4, Bolshaya Pirogovskaya st., 119991, Moscow, Russia

References

  1. Hoog G.S. de, Guarro J., Gene J., Figueras M. J. Atlas of clinical fungi. Utrecht, Reus, 2011. [СD-ROM: electronic version 3.1.]
  2. Zverev V.V., Boychenko M.N. Fundamentals of microbiology and immunology: a textbook / Osnovy mikrobiologii i immunologii. Uchebnik. ed. V.V. Zvereva, M.N. Boychenko, Moscow; GEOTAR-Media, 2014.
  3. Colombo A.L., Guimarães T., CamargoL.F., Richtmann R., Queiroz-Telles Fd., Salles M.J., Cunha C.A., Yasuda M.A., Moretti M.L., Nucci M. Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Brazilian J Inf Dis. May-June 2013. 17(3): 283-312. http //: doi: 10.1016/j.bjid.2013.02.001.
  4. Prilepskaya V.N. Vulvovaginal candidiasis. Clinic, diagnosis, principles of therapy / Vul’vovaginal’nyj kandidoz: klinika, diagnostika, principy terapii. Moscow: GEOTAR-Media, 2010.
  5. Stock I. Fungal diseases of vulva and vagina caused by Candida species. Med. Monatsschr. Pharm. 2010. 33(9): 324-33.
  6. Vazquez J.A., Patton L.L., Epstein J.B., Ramlachan P., Mitha I., Noveljic Z., Fourie J., Conway B. et al. SMiLES Study Group. Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad(R) efficacy and safety (SMiLES). HIV Clin Trials. Jul-Aug 2010; 11(4): 186-96. http//: doi: 10.1310/hct1104-186.
  7. Viljoen J., Azie N., Schmitt-Hoffmann A.H., Ghannoum M. A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis. Antimicrob Agents Chemother. Mar 2015; 59(3): 1671-9. http//: doi: 10.1128/aac.04586-14.
  8. Reinhardt S.W., Spec A., Meléndez J. AIDS-Defining Illnesses at Initial Diagnosis of HIV in a Large Guatemalan Cohort. Open Forum Infect Dis. 2017 Fall; 4(4): ofx249. http//: doi: 10.1093/ofid/ofx249.
  9. Alczuk Sde S., Bonfim-Mendonça Pde S., Rocha-Brischiliari S.C., Shinobu-Mesquita C.S., Martins H.P., Gimenes F. et al. Antiretroviral therapy on vaginal candida spp. isolation in HIV-infected compared to HIV-uninfected women. Rev Inst Med Trop Sao Paulo. 2015 Mar-Apr; 57(2): 169-174. http//: doi: 10.1590/s0036-46652015000200012.
  10. Mazus A.I., Kaminskij G.D., Zimina V.N. Nacional’nye klinicheskie rekomendacii po diagnostike i lecheniyu VICH-infekcii u vzroslyh, 2014: 33-6.
  11. Enoch D., Yang H., Aliyu S.H., Micallef C.The Changing Epidemiology of Invasive Fungal Infections. Methods Mol Biol. 2017; 1508:17-65. http//: doi: 10.1007/978-1-4939-6515-1_2.
  12. Patel P.K., Erlandsen J.E., Kirkpatrick W.R., Berg D.K., Westbrook S.D., Louden C., Cornell J.E., Thompson G.R., Vallor A.C., Wickes B.L., Wiederhold N.P., Redding S.W., Patterson T.F. The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy. AIDS Res Treat. 2012; 2012:262471. http//: doi: 10.1155/2012/262471.
  13. Thanyasrisung P., Kesakomol P., Pipattanagovit P., Youngnak-Piboonratanakit P., Pitiphat W., Matangkasombut O. Oral Candida carriage and immune status in Thai human immunodeficiency virus-infected individuals. J Med Microbiol. May 2014; 63(5): 753-9. http//: doi: 10.1099/jmm.0.069773-0.
  14. Mushi M.F., Mtemisika C.I., Bade rO., Bii C., Mirambo M.M., Groß U., Mshana S.E. High Oral Carriage of Non-albicans Candida spp. among HIV-infected individuals. Int J Infect Dis. Aug 2016; 49: 185-8. http//: doi: 10.1016/j.ijid.2016.07.001
  15. Clark-Ordonez I., Callejas-Negrete O.A., Arechiga-Carvajal E.T., Mourino-Perez R.R. Candida species diversity and antifungal susceptibility patterns in oral samples of HIV/AIDS patients in Baja California, Mexico. Med Mycol. Sep 14 2016. http//: doi: 10.1093/mmy/myw069
  16. Beloborodova N.V., Vostrikova T.U. Monitoring gribkovyh infekcij v ORIT. Klinicheskaya mikrobiologiya, antimikrobnaya khimioterapiya. 2009. 1(11): 22-30.

Copyright (c) 2018 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies